nodes	percent_of_prediction	percent_of_DWPC	metapath
Azithromycin—ABCB1—Mitomycin—urinary bladder cancer	0.163	0.257	CbGbCtD
Azithromycin—CYP2A6—Fluorouracil—urinary bladder cancer	0.121	0.189	CbGbCtD
Azithromycin—CYP3A4—Thiotepa—urinary bladder cancer	0.0742	0.117	CbGbCtD
Azithromycin—ABCB1—Gemcitabine—urinary bladder cancer	0.0471	0.0739	CbGbCtD
Azithromycin—CYP1A2—Fluorouracil—urinary bladder cancer	0.046	0.0723	CbGbCtD
Azithromycin—CYP1A2—Etoposide—urinary bladder cancer	0.0384	0.0603	CbGbCtD
Azithromycin—ABCB1—Cisplatin—urinary bladder cancer	0.0342	0.0537	CbGbCtD
Azithromycin—ABCB1—Etoposide—urinary bladder cancer	0.0336	0.0528	CbGbCtD
Azithromycin—ABCB1—Doxorubicin—urinary bladder cancer	0.0229	0.036	CbGbCtD
Azithromycin—ABCB1—Methotrexate—urinary bladder cancer	0.0222	0.0349	CbGbCtD
Azithromycin—CYP3A4—Etoposide—urinary bladder cancer	0.0201	0.0316	CbGbCtD
Azithromycin—CYP3A4—Doxorubicin—urinary bladder cancer	0.0137	0.0216	CbGbCtD
Azithromycin—CYP1A2—urine—urinary bladder cancer	0.00149	0.206	CbGeAlD
Azithromycin—CYP3A4—urine—urinary bladder cancer	0.00108	0.149	CbGeAlD
Azithromycin—CYP2A6—prostate gland—urinary bladder cancer	0.00102	0.141	CbGeAlD
Azithromycin—CYP2A6—seminal vesicle—urinary bladder cancer	0.000861	0.119	CbGeAlD
Azithromycin—CYP2A6—NRF2 pathway—UGT2B7—urinary bladder cancer	0.000632	0.00951	CbGpPWpGaD
Azithromycin—CYP2A6—Fluoropyrimidine Activity—TYMS—urinary bladder cancer	0.000622	0.00936	CbGpPWpGaD
Azithromycin—CYP1A2—Estrogen metabolism—NQO1—urinary bladder cancer	0.000619	0.00931	CbGpPWpGaD
Azithromycin—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—urinary bladder cancer	0.000619	0.0093	CbGpPWpGaD
Azithromycin—CYP2A6—Biological oxidations—GSTO2—urinary bladder cancer	0.000606	0.00912	CbGpPWpGaD
Azithromycin—CYP2A6—Biological oxidations—NAT1—urinary bladder cancer	0.000606	0.00912	CbGpPWpGaD
Azithromycin—CYP2A6—Fluoropyrimidine Activity—ERCC2—urinary bladder cancer	0.000578	0.0087	CbGpPWpGaD
Azithromycin—ABCB1—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.000557	0.00838	CbGpPWpGaD
Azithromycin—CYP2A6—Biological oxidations—UGT2B7—urinary bladder cancer	0.000555	0.00834	CbGpPWpGaD
Azithromycin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.000551	0.00829	CbGpPWpGaD
Azithromycin—CYP1A2—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.000544	0.00818	CbGpPWpGaD
Azithromycin—CYP2A6—Fluoropyrimidine Activity—MTHFR—urinary bladder cancer	0.000543	0.00817	CbGpPWpGaD
Azithromycin—CYP1A2—Phase II conjugation—GSTZ1—urinary bladder cancer	0.000519	0.00781	CbGpPWpGaD
Azithromycin—CYP2A6—vagina—urinary bladder cancer	0.000503	0.0694	CbGeAlD
Azithromycin—CYP2A6—Biological oxidations—CYP4B1—urinary bladder cancer	0.000499	0.00751	CbGpPWpGaD
Azithromycin—CYP1A2—Phase II conjugation—GSTO2—urinary bladder cancer	0.000492	0.00741	CbGpPWpGaD
Azithromycin—CYP1A2—Phase II conjugation—NAT1—urinary bladder cancer	0.000492	0.00741	CbGpPWpGaD
Azithromycin—CYP1A2—Estrogen Receptor Pathway—ESR1—urinary bladder cancer	0.000483	0.00727	CbGpPWpGaD
Azithromycin—CYP3A4—Estrogen metabolism—NQO1—urinary bladder cancer	0.000478	0.00718	CbGpPWpGaD
Azithromycin—CYP1A2—Estrogen metabolism—GSTM1—urinary bladder cancer	0.000474	0.00714	CbGpPWpGaD
Azithromycin—CYP1A2—Phase II conjugation—UGT2B7—urinary bladder cancer	0.00045	0.00678	CbGpPWpGaD
Azithromycin—CYP1A2—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.000447	0.00672	CbGpPWpGaD
Azithromycin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.000425	0.0064	CbGpPWpGaD
Azithromycin—CYP3A4—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.00042	0.00631	CbGpPWpGaD
Azithromycin—CYP3A4—Estrogen metabolism—GSTM1—urinary bladder cancer	0.000366	0.00551	CbGpPWpGaD
Azithromycin—CYP1A2—renal system—urinary bladder cancer	0.000364	0.0503	CbGeAlD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor—HPGDS—urinary bladder cancer	0.000362	0.00545	CbGpPWpGaD
Azithromycin—CYP3A4—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.000345	0.00518	CbGpPWpGaD
Azithromycin—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.000343	0.00516	CbGpPWpGaD
Azithromycin—CYP1A2—Arachidonic acid metabolism—HPGDS—urinary bladder cancer	0.000339	0.0051	CbGpPWpGaD
Azithromycin—CYP2A6—Biological oxidations—NAT2—urinary bladder cancer	0.000332	0.005	CbGpPWpGaD
Azithromycin—ABCB1—HIF-1-alpha transcription factor network—TFRC—urinary bladder cancer	0.000309	0.00465	CbGpPWpGaD
Azithromycin—CYP1A2—Biological oxidations—GSTZ1—urinary bladder cancer	0.000304	0.00457	CbGpPWpGaD
Azithromycin—CYP1A2—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.0003	0.00451	CbGpPWpGaD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor—NQO1—urinary bladder cancer	0.000292	0.00439	CbGpPWpGaD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NQO1—urinary bladder cancer	0.000292	0.00439	CbGpPWpGaD
Azithromycin—CYP1A2—Biological oxidations—GSTO2—urinary bladder cancer	0.000288	0.00433	CbGpPWpGaD
Azithromycin—CYP1A2—Biological oxidations—NAT1—urinary bladder cancer	0.000288	0.00433	CbGpPWpGaD
Azithromycin—CYP1A2—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000284	0.00427	CbGpPWpGaD
Azithromycin—ABCB1—prostate gland—urinary bladder cancer	0.000274	0.0378	CbGeAlD
Azithromycin—CYP1A2—Phase II conjugation—NAT2—urinary bladder cancer	0.00027	0.00406	CbGpPWpGaD
Azithromycin—CYP2A6—Biological oxidations—HPGDS—urinary bladder cancer	0.000266	0.004	CbGpPWpGaD
Azithromycin—CYP3A4—renal system—urinary bladder cancer	0.000264	0.0364	CbGeAlD
Azithromycin—CYP1A2—Biological oxidations—UGT2B7—urinary bladder cancer	0.000263	0.00396	CbGpPWpGaD
Azithromycin—CYP1A2—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.00026	0.00391	CbGpPWpGaD
Azithromycin—CYP2A6—Biological oxidations—GSTT1—urinary bladder cancer	0.000258	0.00388	CbGpPWpGaD
Azithromycin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000256	0.00385	CbGpPWpGaD
Azithromycin—CYP2A6—NRF2 pathway—NQO1—urinary bladder cancer	0.000244	0.00367	CbGpPWpGaD
Azithromycin—CYP1A2—Biological oxidations—CYP4B1—urinary bladder cancer	0.000237	0.00357	CbGpPWpGaD
Azithromycin—CYP3A4—Biological oxidations—GSTZ1—urinary bladder cancer	0.000235	0.00353	CbGpPWpGaD
Azithromycin—CYP1A2—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000234	0.00352	CbGpPWpGaD
Azithromycin—ABCB1—seminal vesicle—urinary bladder cancer	0.000232	0.032	CbGeAlD
Azithromycin—CYP3A4—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000231	0.00348	CbGpPWpGaD
Azithromycin—CYP3A4—Biological oxidations—GSTO2—urinary bladder cancer	0.000222	0.00334	CbGpPWpGaD
Azithromycin—CYP3A4—Biological oxidations—NAT1—urinary bladder cancer	0.000222	0.00334	CbGpPWpGaD
Azithromycin—Somnolence—Etoposide—urinary bladder cancer	0.000219	0.000757	CcSEcCtD
Azithromycin—CYP3A4—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000219	0.0033	CbGpPWpGaD
Azithromycin—Vomiting—Thiotepa—urinary bladder cancer	0.000218	0.000754	CcSEcCtD
Azithromycin—Pneumonia—Epirubicin—urinary bladder cancer	0.000218	0.000753	CcSEcCtD
Azithromycin—Infestation—Epirubicin—urinary bladder cancer	0.000217	0.000749	CcSEcCtD
Azithromycin—Infestation NOS—Epirubicin—urinary bladder cancer	0.000217	0.000749	CcSEcCtD
Azithromycin—Rash—Thiotepa—urinary bladder cancer	0.000217	0.000748	CcSEcCtD
Azithromycin—Dermatitis—Thiotepa—urinary bladder cancer	0.000216	0.000747	CcSEcCtD
Azithromycin—CYP1A2—Phase II conjugation—HPGDS—urinary bladder cancer	0.000216	0.00324	CbGpPWpGaD
Azithromycin—Headache—Thiotepa—urinary bladder cancer	0.000215	0.000743	CcSEcCtD
Azithromycin—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.000215	0.000742	CcSEcCtD
Azithromycin—Decreased appetite—Etoposide—urinary bladder cancer	0.000215	0.000741	CcSEcCtD
Azithromycin—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000213	0.000735	CcSEcCtD
Azithromycin—Body temperature increased—Cisplatin—urinary bladder cancer	0.000213	0.000735	CcSEcCtD
Azithromycin—Fatigue—Etoposide—urinary bladder cancer	0.000213	0.000734	CcSEcCtD
Azithromycin—Jaundice—Epirubicin—urinary bladder cancer	0.000211	0.00073	CcSEcCtD
Azithromycin—Stomatitis—Epirubicin—urinary bladder cancer	0.000211	0.00073	CcSEcCtD
Azithromycin—CYP3A4—female reproductive system—urinary bladder cancer	0.000211	0.0292	CbGeAlD
Azithromycin—Constipation—Etoposide—urinary bladder cancer	0.000211	0.000728	CcSEcCtD
Azithromycin—Pain—Etoposide—urinary bladder cancer	0.000211	0.000728	CcSEcCtD
Azithromycin—Dysuria—Doxorubicin—urinary bladder cancer	0.00021	0.000727	CcSEcCtD
Azithromycin—Neutropenia—Doxorubicin—urinary bladder cancer	0.00021	0.000727	CcSEcCtD
Azithromycin—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000209	0.000723	CcSEcCtD
Azithromycin—CYP1A2—Phase II conjugation—GSTT1—urinary bladder cancer	0.000209	0.00315	CbGpPWpGaD
Azithromycin—Hepatitis—Methotrexate—urinary bladder cancer	0.000208	0.000718	CcSEcCtD
Azithromycin—Sweating—Epirubicin—urinary bladder cancer	0.000208	0.000718	CcSEcCtD
Azithromycin—Pollakiuria—Doxorubicin—urinary bladder cancer	0.000208	0.000718	CcSEcCtD
Azithromycin—Asthenia—Gemcitabine—urinary bladder cancer	0.000207	0.000716	CcSEcCtD
Azithromycin—CYP2A6—Fluoropyrimidine Activity—TP53—urinary bladder cancer	0.000206	0.0031	CbGpPWpGaD
Azithromycin—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.000205	0.000709	CcSEcCtD
Azithromycin—Pruritus—Gemcitabine—urinary bladder cancer	0.000204	0.000706	CcSEcCtD
Azithromycin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000204	0.00307	CbGpPWpGaD
Azithromycin—Nausea—Thiotepa—urinary bladder cancer	0.000204	0.000704	CcSEcCtD
Azithromycin—CYP2A6—NRF2 pathway—GSTP1—urinary bladder cancer	0.000204	0.00306	CbGpPWpGaD
Azithromycin—Sinusitis—Epirubicin—urinary bladder cancer	0.000204	0.000702	CcSEcCtD
Azithromycin—Feeling abnormal—Etoposide—urinary bladder cancer	0.000203	0.000702	CcSEcCtD
Azithromycin—CYP3A4—Biological oxidations—UGT2B7—urinary bladder cancer	0.000203	0.00306	CbGpPWpGaD
Azithromycin—Pneumonia—Doxorubicin—urinary bladder cancer	0.000202	0.000697	CcSEcCtD
Azithromycin—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000202	0.000697	CcSEcCtD
Azithromycin—ABCB1—epithelium—urinary bladder cancer	0.000201	0.0278	CbGeAlD
Azithromycin—Pruritus—Fluorouracil—urinary bladder cancer	0.000201	0.000694	CcSEcCtD
Azithromycin—Infestation NOS—Doxorubicin—urinary bladder cancer	0.000201	0.000693	CcSEcCtD
Azithromycin—Infestation—Doxorubicin—urinary bladder cancer	0.000201	0.000693	CcSEcCtD
Azithromycin—CYP1A2—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.000201	0.00302	CbGpPWpGaD
Azithromycin—CYP3A4—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000201	0.00302	CbGpPWpGaD
Azithromycin—Visual impairment—Methotrexate—urinary bladder cancer	0.000201	0.000692	CcSEcCtD
Azithromycin—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000199	0.000687	CcSEcCtD
Azithromycin—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000198	0.000685	CcSEcCtD
Azithromycin—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000198	0.000683	CcSEcCtD
Azithromycin—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000197	0.000679	CcSEcCtD
Azithromycin—Urticaria—Etoposide—urinary bladder cancer	0.000196	0.000677	CcSEcCtD
Azithromycin—Stomatitis—Doxorubicin—urinary bladder cancer	0.000196	0.000675	CcSEcCtD
Azithromycin—Jaundice—Doxorubicin—urinary bladder cancer	0.000196	0.000675	CcSEcCtD
Azithromycin—Rhinitis—Epirubicin—urinary bladder cancer	0.000195	0.000674	CcSEcCtD
Azithromycin—Body temperature increased—Etoposide—urinary bladder cancer	0.000195	0.000673	CcSEcCtD
Azithromycin—Abdominal pain—Etoposide—urinary bladder cancer	0.000195	0.000673	CcSEcCtD
Azithromycin—Hepatitis—Epirubicin—urinary bladder cancer	0.000195	0.000672	CcSEcCtD
Azithromycin—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000194	0.000671	CcSEcCtD
Azithromycin—Tinnitus—Methotrexate—urinary bladder cancer	0.000194	0.00067	CcSEcCtD
Azithromycin—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000194	0.000669	CcSEcCtD
Azithromycin—Asthenia—Cisplatin—urinary bladder cancer	0.000193	0.000667	CcSEcCtD
Azithromycin—Sweating—Doxorubicin—urinary bladder cancer	0.000192	0.000664	CcSEcCtD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—LIG1—urinary bladder cancer	0.000191	0.00287	CbGpPWpGaD
Azithromycin—Sinusitis—Doxorubicin—urinary bladder cancer	0.000188	0.00065	CcSEcCtD
Azithromycin—Dizziness—Fluorouracil—urinary bladder cancer	0.000188	0.000649	CcSEcCtD
Azithromycin—Visual impairment—Epirubicin—urinary bladder cancer	0.000188	0.000648	CcSEcCtD
Azithromycin—CYP2A6—NRF2 pathway—GSTM1—urinary bladder cancer	0.000187	0.00281	CbGpPWpGaD
Azithromycin—ABCB1—renal system—urinary bladder cancer	0.000187	0.0258	CbGeAlD
Azithromycin—Chills—Methotrexate—urinary bladder cancer	0.000187	0.000644	CcSEcCtD
Azithromycin—ABCB1—HIF-1-alpha transcription factor network—TERT—urinary bladder cancer	0.000185	0.00279	CbGpPWpGaD
Azithromycin—Diarrhoea—Cisplatin—urinary bladder cancer	0.000184	0.000636	CcSEcCtD
Azithromycin—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000184	0.000636	CcSEcCtD
Azithromycin—Vomiting—Gemcitabine—urinary bladder cancer	0.000184	0.000634	CcSEcCtD
Azithromycin—ABCB1—urethra—urinary bladder cancer	0.000183	0.0253	CbGeAlD
Azithromycin—CYP3A4—Biological oxidations—CYP4B1—urinary bladder cancer	0.000183	0.00275	CbGpPWpGaD
Azithromycin—Rash—Gemcitabine—urinary bladder cancer	0.000182	0.000629	CcSEcCtD
Azithromycin—Dermatitis—Gemcitabine—urinary bladder cancer	0.000182	0.000628	CcSEcCtD
Azithromycin—Hypersensitivity—Etoposide—urinary bladder cancer	0.000182	0.000628	CcSEcCtD
Azithromycin—Tinnitus—Epirubicin—urinary bladder cancer	0.000182	0.000627	CcSEcCtD
Azithromycin—Headache—Gemcitabine—urinary bladder cancer	0.000181	0.000625	CcSEcCtD
Azithromycin—Vomiting—Fluorouracil—urinary bladder cancer	0.000181	0.000624	CcSEcCtD
Azithromycin—Rhinitis—Doxorubicin—urinary bladder cancer	0.000181	0.000623	CcSEcCtD
Azithromycin—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000181	0.00272	CbGpPWpGaD
Azithromycin—Hepatitis—Doxorubicin—urinary bladder cancer	0.00018	0.000622	CcSEcCtD
Azithromycin—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000179	0.000619	CcSEcCtD
Azithromycin—Rash—Fluorouracil—urinary bladder cancer	0.000179	0.000618	CcSEcCtD
Azithromycin—Dermatitis—Fluorouracil—urinary bladder cancer	0.000179	0.000618	CcSEcCtD
Azithromycin—CYP2A6—Biological oxidations—GSTP1—urinary bladder cancer	0.000179	0.00269	CbGpPWpGaD
Azithromycin—Headache—Fluorouracil—urinary bladder cancer	0.000178	0.000615	CcSEcCtD
Azithromycin—Dysgeusia—Methotrexate—urinary bladder cancer	0.000177	0.000612	CcSEcCtD
Azithromycin—Asthenia—Etoposide—urinary bladder cancer	0.000177	0.000611	CcSEcCtD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—urinary bladder cancer	0.000176	0.00265	CbGpPWpGaD
Azithromycin—Chills—Epirubicin—urinary bladder cancer	0.000175	0.000603	CcSEcCtD
Azithromycin—Pruritus—Etoposide—urinary bladder cancer	0.000175	0.000603	CcSEcCtD
Azithromycin—Arrhythmia—Epirubicin—urinary bladder cancer	0.000174	0.0006	CcSEcCtD
Azithromycin—Visual impairment—Doxorubicin—urinary bladder cancer	0.000174	0.000599	CcSEcCtD
Azithromycin—Nausea—Gemcitabine—urinary bladder cancer	0.000172	0.000593	CcSEcCtD
Azithromycin—Vomiting—Cisplatin—urinary bladder cancer	0.000171	0.000591	CcSEcCtD
Azithromycin—Vision blurred—Methotrexate—urinary bladder cancer	0.000171	0.000589	CcSEcCtD
Azithromycin—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.00017	0.000588	CcSEcCtD
Azithromycin—Rash—Cisplatin—urinary bladder cancer	0.00017	0.000586	CcSEcCtD
Azithromycin—Dermatitis—Cisplatin—urinary bladder cancer	0.00017	0.000586	CcSEcCtD
Azithromycin—Diarrhoea—Etoposide—urinary bladder cancer	0.000169	0.000583	CcSEcCtD
Azithromycin—Nausea—Fluorouracil—urinary bladder cancer	0.000169	0.000583	CcSEcCtD
Azithromycin—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000168	0.00058	CcSEcCtD
Azithromycin—Tinnitus—Doxorubicin—urinary bladder cancer	0.000168	0.00058	CcSEcCtD
Azithromycin—Anaemia—Methotrexate—urinary bladder cancer	0.000167	0.000578	CcSEcCtD
Azithromycin—Flatulence—Epirubicin—urinary bladder cancer	0.000167	0.000577	CcSEcCtD
Azithromycin—Tension—Epirubicin—urinary bladder cancer	0.000166	0.000574	CcSEcCtD
Azithromycin—Dysgeusia—Epirubicin—urinary bladder cancer	0.000166	0.000573	CcSEcCtD
Azithromycin—Nervousness—Epirubicin—urinary bladder cancer	0.000165	0.000568	CcSEcCtD
Azithromycin—CYP2A6—Biological oxidations—GSTM1—urinary bladder cancer	0.000164	0.00247	CbGpPWpGaD
Azithromycin—Malaise—Methotrexate—urinary bladder cancer	0.000163	0.000564	CcSEcCtD
Azithromycin—Dizziness—Etoposide—urinary bladder cancer	0.000163	0.000563	CcSEcCtD
Azithromycin—ABCB1—Allograft Rejection—FAS—urinary bladder cancer	0.000163	0.00245	CbGpPWpGaD
Azithromycin—Vertigo—Methotrexate—urinary bladder cancer	0.000163	0.000562	CcSEcCtD
Azithromycin—Leukopenia—Methotrexate—urinary bladder cancer	0.000162	0.00056	CcSEcCtD
Azithromycin—Chills—Doxorubicin—urinary bladder cancer	0.000162	0.000558	CcSEcCtD
Azithromycin—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000161	0.000556	CcSEcCtD
Azithromycin—Nausea—Cisplatin—urinary bladder cancer	0.00016	0.000552	CcSEcCtD
Azithromycin—Vision blurred—Epirubicin—urinary bladder cancer	0.00016	0.000551	CcSEcCtD
Azithromycin—Cough—Methotrexate—urinary bladder cancer	0.000158	0.000546	CcSEcCtD
Azithromycin—CYP1A2—Biological oxidations—NAT2—urinary bladder cancer	0.000158	0.00237	CbGpPWpGaD
Azithromycin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000158	0.00237	CbGpPWpGaD
Azithromycin—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000157	0.000543	CcSEcCtD
Azithromycin—Convulsion—Methotrexate—urinary bladder cancer	0.000157	0.000542	CcSEcCtD
Azithromycin—Vomiting—Etoposide—urinary bladder cancer	0.000157	0.000542	CcSEcCtD
Azithromycin—Anaemia—Epirubicin—urinary bladder cancer	0.000157	0.000541	CcSEcCtD
Azithromycin—Agitation—Epirubicin—urinary bladder cancer	0.000156	0.000538	CcSEcCtD
Azithromycin—CYP1A2—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000156	0.00234	CbGpPWpGaD
Azithromycin—Rash—Etoposide—urinary bladder cancer	0.000156	0.000537	CcSEcCtD
Azithromycin—Dermatitis—Etoposide—urinary bladder cancer	0.000155	0.000537	CcSEcCtD
Azithromycin—Headache—Etoposide—urinary bladder cancer	0.000155	0.000534	CcSEcCtD
Azithromycin—Flatulence—Doxorubicin—urinary bladder cancer	0.000155	0.000533	CcSEcCtD
Azithromycin—Chest pain—Methotrexate—urinary bladder cancer	0.000154	0.000532	CcSEcCtD
Azithromycin—Myalgia—Methotrexate—urinary bladder cancer	0.000154	0.000532	CcSEcCtD
Azithromycin—Arthralgia—Methotrexate—urinary bladder cancer	0.000154	0.000532	CcSEcCtD
Azithromycin—Tension—Doxorubicin—urinary bladder cancer	0.000154	0.000531	CcSEcCtD
Azithromycin—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000154	0.00053	CcSEcCtD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor—RB1—urinary bladder cancer	0.000154	0.00231	CbGpPWpGaD
Azithromycin—Malaise—Epirubicin—urinary bladder cancer	0.000153	0.000528	CcSEcCtD
Azithromycin—Discomfort—Methotrexate—urinary bladder cancer	0.000152	0.000526	CcSEcCtD
Azithromycin—Nervousness—Doxorubicin—urinary bladder cancer	0.000152	0.000526	CcSEcCtD
Azithromycin—Vertigo—Epirubicin—urinary bladder cancer	0.000152	0.000526	CcSEcCtD
Azithromycin—Syncope—Epirubicin—urinary bladder cancer	0.000152	0.000525	CcSEcCtD
Azithromycin—Leukopenia—Epirubicin—urinary bladder cancer	0.000152	0.000524	CcSEcCtD
Azithromycin—Palpitations—Epirubicin—urinary bladder cancer	0.00015	0.000517	CcSEcCtD
Azithromycin—ABCB1—female reproductive system—urinary bladder cancer	0.00015	0.0207	CbGeAlD
Azithromycin—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000149	0.000514	CcSEcCtD
Azithromycin—Cough—Epirubicin—urinary bladder cancer	0.000148	0.000511	CcSEcCtD
Azithromycin—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000148	0.00051	CcSEcCtD
Azithromycin—Vision blurred—Doxorubicin—urinary bladder cancer	0.000148	0.00051	CcSEcCtD
Azithromycin—Convulsion—Epirubicin—urinary bladder cancer	0.000147	0.000507	CcSEcCtD
Azithromycin—Infection—Methotrexate—urinary bladder cancer	0.000147	0.000507	CcSEcCtD
Azithromycin—Nausea—Etoposide—urinary bladder cancer	0.000147	0.000506	CcSEcCtD
Azithromycin—Hypertension—Epirubicin—urinary bladder cancer	0.000146	0.000505	CcSEcCtD
Azithromycin—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000146	0.000502	CcSEcCtD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	0.000145	0.00219	CbGpPWpGaD
Azithromycin—CYP1A2—Phase II conjugation—GSTP1—urinary bladder cancer	0.000145	0.00218	CbGpPWpGaD
Azithromycin—Anaemia—Doxorubicin—urinary bladder cancer	0.000145	0.0005	CcSEcCtD
Azithromycin—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000145	0.0005	CcSEcCtD
Azithromycin—ABCB1—HIF-1-alpha transcription factor network—CREBBP—urinary bladder cancer	0.000145	0.00218	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	0.000144	0.00217	CbGpPWpGaD
Azithromycin—Chest pain—Epirubicin—urinary bladder cancer	0.000144	0.000498	CcSEcCtD
Azithromycin—Myalgia—Epirubicin—urinary bladder cancer	0.000144	0.000498	CcSEcCtD
Azithromycin—Arthralgia—Epirubicin—urinary bladder cancer	0.000144	0.000498	CcSEcCtD
Azithromycin—Agitation—Doxorubicin—urinary bladder cancer	0.000144	0.000498	CcSEcCtD
Azithromycin—Anxiety—Epirubicin—urinary bladder cancer	0.000144	0.000496	CcSEcCtD
Azithromycin—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000143	0.000493	CcSEcCtD
Azithromycin—Discomfort—Epirubicin—urinary bladder cancer	0.000143	0.000492	CcSEcCtD
Azithromycin—Malaise—Doxorubicin—urinary bladder cancer	0.000141	0.000488	CcSEcCtD
Azithromycin—Dry mouth—Epirubicin—urinary bladder cancer	0.000141	0.000487	CcSEcCtD
Azithromycin—Vertigo—Doxorubicin—urinary bladder cancer	0.000141	0.000486	CcSEcCtD
Azithromycin—Anorexia—Methotrexate—urinary bladder cancer	0.000141	0.000486	CcSEcCtD
Azithromycin—Syncope—Doxorubicin—urinary bladder cancer	0.000141	0.000486	CcSEcCtD
Azithromycin—Leukopenia—Doxorubicin—urinary bladder cancer	0.00014	0.000485	CcSEcCtD
Azithromycin—Palpitations—Doxorubicin—urinary bladder cancer	0.000139	0.000478	CcSEcCtD
Azithromycin—Oedema—Epirubicin—urinary bladder cancer	0.000138	0.000478	CcSEcCtD
Azithromycin—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000138	0.000478	CcSEcCtD
Azithromycin—Hypotension—Methotrexate—urinary bladder cancer	0.000138	0.000477	CcSEcCtD
Azithromycin—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000138	0.000476	CcSEcCtD
Azithromycin—Infection—Epirubicin—urinary bladder cancer	0.000137	0.000474	CcSEcCtD
Azithromycin—Cough—Doxorubicin—urinary bladder cancer	0.000137	0.000472	CcSEcCtD
Azithromycin—Shock—Epirubicin—urinary bladder cancer	0.000136	0.00047	CcSEcCtD
Azithromycin—Convulsion—Doxorubicin—urinary bladder cancer	0.000136	0.000469	CcSEcCtD
Azithromycin—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000135	0.000468	CcSEcCtD
Azithromycin—Hypertension—Doxorubicin—urinary bladder cancer	0.000135	0.000467	CcSEcCtD
Azithromycin—ABCB1—vagina—urinary bladder cancer	0.000135	0.0187	CbGeAlD
Azithromycin—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000135	0.000465	CcSEcCtD
Azithromycin—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000134	0.000462	CcSEcCtD
Azithromycin—Insomnia—Methotrexate—urinary bladder cancer	0.000134	0.000462	CcSEcCtD
Azithromycin—Chest pain—Doxorubicin—urinary bladder cancer	0.000134	0.000461	CcSEcCtD
Azithromycin—Arthralgia—Doxorubicin—urinary bladder cancer	0.000134	0.000461	CcSEcCtD
Azithromycin—Myalgia—Doxorubicin—urinary bladder cancer	0.000134	0.000461	CcSEcCtD
Azithromycin—CYP1A2—Phase II conjugation—GSTM1—urinary bladder cancer	0.000133	0.002	CbGpPWpGaD
Azithromycin—Anxiety—Doxorubicin—urinary bladder cancer	0.000133	0.000459	CcSEcCtD
Azithromycin—Paraesthesia—Methotrexate—urinary bladder cancer	0.000133	0.000458	CcSEcCtD
Azithromycin—Discomfort—Doxorubicin—urinary bladder cancer	0.000132	0.000455	CcSEcCtD
Azithromycin—Anorexia—Epirubicin—urinary bladder cancer	0.000132	0.000455	CcSEcCtD
Azithromycin—Dyspnoea—Methotrexate—urinary bladder cancer	0.000132	0.000455	CcSEcCtD
Azithromycin—ABCB1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000132	0.00198	CbGpPWpGaD
Azithromycin—Somnolence—Methotrexate—urinary bladder cancer	0.000131	0.000454	CcSEcCtD
Azithromycin—Dry mouth—Doxorubicin—urinary bladder cancer	0.000131	0.000451	CcSEcCtD
Azithromycin—Dyspepsia—Methotrexate—urinary bladder cancer	0.00013	0.000449	CcSEcCtD
Azithromycin—Hypotension—Epirubicin—urinary bladder cancer	0.000129	0.000446	CcSEcCtD
Azithromycin—Decreased appetite—Methotrexate—urinary bladder cancer	0.000129	0.000444	CcSEcCtD
Azithromycin—Oedema—Doxorubicin—urinary bladder cancer	0.000128	0.000442	CcSEcCtD
Azithromycin—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000128	0.000442	CcSEcCtD
Azithromycin—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000128	0.000441	CcSEcCtD
Azithromycin—Fatigue—Methotrexate—urinary bladder cancer	0.000127	0.00044	CcSEcCtD
Azithromycin—Infection—Doxorubicin—urinary bladder cancer	0.000127	0.000439	CcSEcCtD
Azithromycin—Pain—Methotrexate—urinary bladder cancer	0.000126	0.000436	CcSEcCtD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—urinary bladder cancer	0.000126	0.0019	CbGpPWpGaD
Azithromycin—CYP1A2—Biological oxidations—HPGDS—urinary bladder cancer	0.000126	0.0019	CbGpPWpGaD
Azithromycin—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000126	0.000435	CcSEcCtD
Azithromycin—Shock—Doxorubicin—urinary bladder cancer	0.000126	0.000435	CcSEcCtD
Azithromycin—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000125	0.000433	CcSEcCtD
Azithromycin—Insomnia—Epirubicin—urinary bladder cancer	0.000125	0.000432	CcSEcCtD
Azithromycin—Paraesthesia—Epirubicin—urinary bladder cancer	0.000124	0.000429	CcSEcCtD
Azithromycin—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000124	0.000427	CcSEcCtD
Azithromycin—Dyspnoea—Epirubicin—urinary bladder cancer	0.000123	0.000426	CcSEcCtD
Azithromycin—Somnolence—Epirubicin—urinary bladder cancer	0.000123	0.000425	CcSEcCtD
Azithromycin—CYP1A2—Biological oxidations—GSTT1—urinary bladder cancer	0.000122	0.00184	CbGpPWpGaD
Azithromycin—Anorexia—Doxorubicin—urinary bladder cancer	0.000122	0.000421	CcSEcCtD
Azithromycin—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	0.000122	0.00183	CbGpPWpGaD
Azithromycin—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000122	0.00042	CcSEcCtD
Azithromycin—Dyspepsia—Epirubicin—urinary bladder cancer	0.000122	0.00042	CcSEcCtD
Azithromycin—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000121	0.000417	CcSEcCtD
Azithromycin—Decreased appetite—Epirubicin—urinary bladder cancer	0.00012	0.000415	CcSEcCtD
Azithromycin—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	0.00012	0.00181	CbGpPWpGaD
Azithromycin—Hypotension—Doxorubicin—urinary bladder cancer	0.00012	0.000413	CcSEcCtD
Azithromycin—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000119	0.000412	CcSEcCtD
Azithromycin—Fatigue—Epirubicin—urinary bladder cancer	0.000119	0.000412	CcSEcCtD
Azithromycin—Pain—Epirubicin—urinary bladder cancer	0.000118	0.000408	CcSEcCtD
Azithromycin—Constipation—Epirubicin—urinary bladder cancer	0.000118	0.000408	CcSEcCtD
Azithromycin—CYP1A2—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000118	0.00178	CbGpPWpGaD
Azithromycin—Urticaria—Methotrexate—urinary bladder cancer	0.000117	0.000405	CcSEcCtD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—urinary bladder cancer	0.000117	0.00176	CbGpPWpGaD
Azithromycin—Body temperature increased—Methotrexate—urinary bladder cancer	0.000117	0.000403	CcSEcCtD
Azithromycin—Abdominal pain—Methotrexate—urinary bladder cancer	0.000117	0.000403	CcSEcCtD
Azithromycin—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000117	0.000403	CcSEcCtD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	0.000116	0.00175	CbGpPWpGaD
Azithromycin—Insomnia—Doxorubicin—urinary bladder cancer	0.000116	0.0004	CcSEcCtD
Azithromycin—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000115	0.000397	CcSEcCtD
Azithromycin—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000114	0.000394	CcSEcCtD
Azithromycin—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000114	0.000394	CcSEcCtD
Azithromycin—Somnolence—Doxorubicin—urinary bladder cancer	0.000114	0.000393	CcSEcCtD
Azithromycin—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000113	0.00039	CcSEcCtD
Azithromycin—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000113	0.000389	CcSEcCtD
Azithromycin—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000111	0.000384	CcSEcCtD
Azithromycin—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000111	0.000381	CcSEcCtD
Azithromycin—Fatigue—Doxorubicin—urinary bladder cancer	0.00011	0.000381	CcSEcCtD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	0.00011	0.00166	CbGpPWpGaD
Azithromycin—Urticaria—Epirubicin—urinary bladder cancer	0.00011	0.000379	CcSEcCtD
Azithromycin—Constipation—Doxorubicin—urinary bladder cancer	0.000109	0.000378	CcSEcCtD
Azithromycin—Pain—Doxorubicin—urinary bladder cancer	0.000109	0.000378	CcSEcCtD
Azithromycin—CYP2A6—Metabolism—GSTZ1—urinary bladder cancer	0.000109	0.00165	CbGpPWpGaD
Azithromycin—Abdominal pain—Epirubicin—urinary bladder cancer	0.000109	0.000377	CcSEcCtD
Azithromycin—Body temperature increased—Epirubicin—urinary bladder cancer	0.000109	0.000377	CcSEcCtD
Azithromycin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—urinary bladder cancer	0.000109	0.00164	CbGpPWpGaD
Azithromycin—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000109	0.000376	CcSEcCtD
Azithromycin—Asthenia—Methotrexate—urinary bladder cancer	0.000106	0.000366	CcSEcCtD
Azithromycin—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000105	0.000364	CcSEcCtD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	0.000105	0.00158	CbGpPWpGaD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—urinary bladder cancer	0.000105	0.00158	CbGpPWpGaD
Azithromycin—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000105	0.000361	CcSEcCtD
Azithromycin—Pruritus—Methotrexate—urinary bladder cancer	0.000105	0.000361	CcSEcCtD
Azithromycin—CYP2A6—Metabolism—GSTO2—urinary bladder cancer	0.000104	0.00156	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—NAT1—urinary bladder cancer	0.000104	0.00156	CbGpPWpGaD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	0.000102	0.00154	CbGpPWpGaD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—urinary bladder cancer	0.000102	0.00154	CbGpPWpGaD
Azithromycin—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000102	0.000352	CcSEcCtD
Azithromycin—Urticaria—Doxorubicin—urinary bladder cancer	0.000102	0.000351	CcSEcCtD
Azithromycin—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000101	0.000349	CcSEcCtD
Azithromycin—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000101	0.000349	CcSEcCtD
Azithromycin—Diarrhoea—Methotrexate—urinary bladder cancer	0.000101	0.000349	CcSEcCtD
Azithromycin—ABCB1—Allograft Rejection—CXCL8—urinary bladder cancer	9.95e-05	0.0015	CbGpPWpGaD
Azithromycin—Asthenia—Epirubicin—urinary bladder cancer	9.93e-05	0.000343	CcSEcCtD
Azithromycin—ABCB1—HIF-1-alpha transcription factor network—EP300—urinary bladder cancer	9.85e-05	0.00148	CbGpPWpGaD
Azithromycin—Pruritus—Epirubicin—urinary bladder cancer	9.79e-05	0.000338	CcSEcCtD
Azithromycin—Dizziness—Methotrexate—urinary bladder cancer	9.78e-05	0.000337	CcSEcCtD
Azithromycin—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	9.74e-05	0.00146	CbGpPWpGaD
Azithromycin—ABCB1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	9.53e-05	0.00143	CbGpPWpGaD
Azithromycin—ABCB1—Allograft Rejection—IL2—urinary bladder cancer	9.51e-05	0.00143	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—UGT2B7—urinary bladder cancer	9.49e-05	0.00143	CbGpPWpGaD
Azithromycin—Diarrhoea—Epirubicin—urinary bladder cancer	9.47e-05	0.000327	CcSEcCtD
Azithromycin—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	9.45e-05	0.00142	CbGpPWpGaD
Azithromycin—Hypersensitivity—Doxorubicin—urinary bladder cancer	9.43e-05	0.000326	CcSEcCtD
Azithromycin—Vomiting—Methotrexate—urinary bladder cancer	9.4e-05	0.000324	CcSEcCtD
Azithromycin—Rash—Methotrexate—urinary bladder cancer	9.32e-05	0.000322	CcSEcCtD
Azithromycin—Dermatitis—Methotrexate—urinary bladder cancer	9.31e-05	0.000321	CcSEcCtD
Azithromycin—Headache—Methotrexate—urinary bladder cancer	9.26e-05	0.00032	CcSEcCtD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	9.25e-05	0.00139	CbGpPWpGaD
Azithromycin—Asthenia—Doxorubicin—urinary bladder cancer	9.18e-05	0.000317	CcSEcCtD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	9.15e-05	0.00138	CbGpPWpGaD
Azithromycin—Dizziness—Epirubicin—urinary bladder cancer	9.15e-05	0.000316	CcSEcCtD
Azithromycin—CYP1A2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	9.11e-05	0.00137	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	9.09e-05	0.00137	CbGpPWpGaD
Azithromycin—Pruritus—Doxorubicin—urinary bladder cancer	9.06e-05	0.000313	CcSEcCtD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	8.95e-05	0.00135	CbGpPWpGaD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	8.95e-05	0.00135	CbGpPWpGaD
Azithromycin—Vomiting—Epirubicin—urinary bladder cancer	8.8e-05	0.000304	CcSEcCtD
Azithromycin—Nausea—Methotrexate—urinary bladder cancer	8.78e-05	0.000303	CcSEcCtD
Azithromycin—Diarrhoea—Doxorubicin—urinary bladder cancer	8.76e-05	0.000302	CcSEcCtD
Azithromycin—ABCB1—lymph node—urinary bladder cancer	8.75e-05	0.0121	CbGeAlD
Azithromycin—Rash—Epirubicin—urinary bladder cancer	8.72e-05	0.000301	CcSEcCtD
Azithromycin—Dermatitis—Epirubicin—urinary bladder cancer	8.72e-05	0.000301	CcSEcCtD
Azithromycin—Headache—Epirubicin—urinary bladder cancer	8.67e-05	0.000299	CcSEcCtD
Azithromycin—CYP2A6—Metabolism—CYP4B1—urinary bladder cancer	8.54e-05	0.00128	CbGpPWpGaD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	8.52e-05	0.00128	CbGpPWpGaD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	8.52e-05	0.00128	CbGpPWpGaD
Azithromycin—CYP1A2—Biological oxidations—GSTP1—urinary bladder cancer	8.48e-05	0.00128	CbGpPWpGaD
Azithromycin—Dizziness—Doxorubicin—urinary bladder cancer	8.47e-05	0.000292	CcSEcCtD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	8.45e-05	0.00127	CbGpPWpGaD
Azithromycin—CYP1A2—Metapathway biotransformation—GSTP1—urinary bladder cancer	8.37e-05	0.00126	CbGpPWpGaD
Azithromycin—Nausea—Epirubicin—urinary bladder cancer	8.22e-05	0.000284	CcSEcCtD
Azithromycin—Vomiting—Doxorubicin—urinary bladder cancer	8.14e-05	0.000281	CcSEcCtD
Azithromycin—Rash—Doxorubicin—urinary bladder cancer	8.07e-05	0.000279	CcSEcCtD
Azithromycin—CYP2A6—Metabolism—SLC19A1—urinary bladder cancer	8.07e-05	0.00121	CbGpPWpGaD
Azithromycin—Dermatitis—Doxorubicin—urinary bladder cancer	8.06e-05	0.000278	CcSEcCtD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	8.05e-05	0.00121	CbGpPWpGaD
Azithromycin—Headache—Doxorubicin—urinary bladder cancer	8.02e-05	0.000277	CcSEcCtD
Azithromycin—CYP2A6—Metabolism—PRSS3—urinary bladder cancer	7.86e-05	0.00118	CbGpPWpGaD
Azithromycin—CYP1A2—Biological oxidations—GSTM1—urinary bladder cancer	7.8e-05	0.00117	CbGpPWpGaD
Azithromycin—ABCB1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	7.77e-05	0.00117	CbGpPWpGaD
Azithromycin—CYP1A2—Metapathway biotransformation—GSTM1—urinary bladder cancer	7.69e-05	0.00116	CbGpPWpGaD
Azithromycin—Nausea—Doxorubicin—urinary bladder cancer	7.6e-05	0.000262	CcSEcCtD
Azithromycin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	7.19e-05	0.00108	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	7.11e-05	0.00107	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	7.08e-05	0.00107	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	7.05e-05	0.00106	CbGpPWpGaD
Azithromycin—ABCB1—Allograft Rejection—TNF—urinary bladder cancer	6.93e-05	0.00104	CbGpPWpGaD
Azithromycin—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	6.55e-05	0.000985	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	6.51e-05	0.000979	CbGpPWpGaD
Azithromycin—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	6.46e-05	0.000971	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—TYMP—urinary bladder cancer	6.28e-05	0.000945	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	6.18e-05	0.00093	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—GSTO2—urinary bladder cancer	6.17e-05	0.000928	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—NAT1—urinary bladder cancer	6.17e-05	0.000928	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	6.11e-05	0.000918	CbGpPWpGaD
Azithromycin—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	6.02e-05	0.000905	CbGpPWpGaD
Azithromycin—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	5.93e-05	0.000893	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—NAT2—urinary bladder cancer	5.68e-05	0.000855	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	5.64e-05	0.000849	CbGpPWpGaD
Azithromycin—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	5.25e-05	0.000789	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	5.2e-05	0.000782	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	5.18e-05	0.000779	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	5.08e-05	0.000764	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	5.06e-05	0.000762	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	4.93e-05	0.000741	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—NAT1—urinary bladder cancer	4.93e-05	0.000741	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—RRM2—urinary bladder cancer	4.91e-05	0.000738	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	4.85e-05	0.000729	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	4.8e-05	0.000722	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—PRSS3—urinary bladder cancer	4.68e-05	0.000704	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	4.57e-05	0.000688	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—HPGDS—urinary bladder cancer	4.54e-05	0.000683	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—ENO2—urinary bladder cancer	4.54e-05	0.000683	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	4.51e-05	0.000678	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	4.43e-05	0.000666	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	4.42e-05	0.000664	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—GSTT1—urinary bladder cancer	4.41e-05	0.000663	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	4.21e-05	0.000633	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	4.09e-05	0.000616	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	4.06e-05	0.00061	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	4.01e-05	0.000603	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	3.83e-05	0.000576	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	3.8e-05	0.000572	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—NAT1—urinary bladder cancer	3.8e-05	0.000572	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—TYMP—urinary bladder cancer	3.74e-05	0.000562	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	3.73e-05	0.000562	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	3.67e-05	0.000552	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—NQO1—urinary bladder cancer	3.66e-05	0.000551	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	3.59e-05	0.00054	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	3.48e-05	0.000523	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	3.42e-05	0.000514	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	3.39e-05	0.00051	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—NAT2—urinary bladder cancer	3.38e-05	0.000509	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	3.13e-05	0.000471	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—GSTP1—urinary bladder cancer	3.05e-05	0.000459	CbGpPWpGaD
Azithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	3.01e-05	0.000453	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.99e-05	0.00045	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—TYMP—urinary bladder cancer	2.98e-05	0.000449	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	2.96e-05	0.000445	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—RRM2—urinary bladder cancer	2.92e-05	0.000439	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	2.88e-05	0.000433	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.87e-05	0.000431	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—TYMS—urinary bladder cancer	2.84e-05	0.000427	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—NCOR1—urinary bladder cancer	2.81e-05	0.000422	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—GSTM1—urinary bladder cancer	2.81e-05	0.000422	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—ENO2—urinary bladder cancer	2.7e-05	0.000407	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—HPGDS—urinary bladder cancer	2.7e-05	0.000407	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—NAT2—urinary bladder cancer	2.7e-05	0.000406	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—GPX1—urinary bladder cancer	2.69e-05	0.000404	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—ERCC2—urinary bladder cancer	2.64e-05	0.000397	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—GSTT1—urinary bladder cancer	2.62e-05	0.000394	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—MTHFR—urinary bladder cancer	2.48e-05	0.000373	CbGpPWpGaD
Azithromycin—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.45e-05	0.000369	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—RRM2—urinary bladder cancer	2.33e-05	0.000351	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—TYMP—urinary bladder cancer	2.3e-05	0.000347	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—NQO1—urinary bladder cancer	2.18e-05	0.000328	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—ENO2—urinary bladder cancer	2.16e-05	0.000325	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	2.16e-05	0.000325	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.15e-05	0.000323	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	2.09e-05	0.000315	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—NAT2—urinary bladder cancer	2.08e-05	0.000313	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.06e-05	0.00031	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—PPARG—urinary bladder cancer	2.01e-05	0.000303	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—CREBBP—urinary bladder cancer	1.93e-05	0.000291	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—GSTP1—urinary bladder cancer	1.82e-05	0.000273	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.8e-05	0.000271	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—NQO1—urinary bladder cancer	1.74e-05	0.000262	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—TYMS—urinary bladder cancer	1.69e-05	0.000254	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.69e-05	0.000254	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—NCOR1—urinary bladder cancer	1.67e-05	0.000251	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—GSTM1—urinary bladder cancer	1.67e-05	0.000251	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.67e-05	0.000251	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.67e-05	0.000251	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.62e-05	0.000243	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—GPX1—urinary bladder cancer	1.6e-05	0.000241	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—PTGS2—urinary bladder cancer	1.58e-05	0.000238	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—ERCC2—urinary bladder cancer	1.57e-05	0.000236	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—MTHFR—urinary bladder cancer	1.48e-05	0.000222	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.47e-05	0.000221	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	1.45e-05	0.000218	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.4e-05	0.000211	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—PTEN—urinary bladder cancer	1.38e-05	0.000208	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—TYMS—urinary bladder cancer	1.35e-05	0.000203	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.34e-05	0.000202	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	1.33e-05	0.000201	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	1.33e-05	0.000201	CbGpPWpGaD
Azithromycin—CYP2A6—Metabolism—EP300—urinary bladder cancer	1.32e-05	0.000198	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—GPX1—urinary bladder cancer	1.28e-05	0.000192	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	1.25e-05	0.000189	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—PPARG—urinary bladder cancer	1.2e-05	0.00018	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	1.18e-05	0.000177	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—CREBBP—urinary bladder cancer	1.15e-05	0.000173	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.12e-05	0.000168	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.04e-05	0.000157	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.03e-05	0.000155	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.03e-05	0.000155	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—GPX1—urinary bladder cancer	9.85e-06	0.000148	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	9.67e-06	0.000146	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—PPARG—urinary bladder cancer	9.55e-06	0.000144	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—PTGS2—urinary bladder cancer	9.42e-06	0.000142	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	9.18e-06	0.000138	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	9.09e-06	0.000137	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—PTEN—urinary bladder cancer	8.21e-06	0.000124	CbGpPWpGaD
Azithromycin—ABCB1—Metabolism—EP300—urinary bladder cancer	7.83e-06	0.000118	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	7.52e-06	0.000113	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—PPARG—urinary bladder cancer	7.37e-06	0.000111	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	7.08e-06	0.000107	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—PTEN—urinary bladder cancer	6.56e-06	9.86e-05	CbGpPWpGaD
Azithromycin—CYP1A2—Metabolism—EP300—urinary bladder cancer	6.25e-06	9.4e-05	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	5.8e-06	8.73e-05	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—PTEN—urinary bladder cancer	5.06e-06	7.61e-05	CbGpPWpGaD
Azithromycin—CYP3A4—Metabolism—EP300—urinary bladder cancer	4.82e-06	7.26e-05	CbGpPWpGaD
